Form 8-K - Current report:
SEC Accession No. 0001104659-21-049830
Filing Date
2021-04-13
Accepted
2021-04-13 17:26:37
Documents
14
Period of Report
2021-04-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2112882d1_8k.htm   iXBRL 8-K 25729
2 EXHIBIT 99.1 tm2112882d1_ex99-1.htm EX-99.1 28795
6 GRAPHIC tm2112882d1_ex99-1image001.jpg GRAPHIC 6269
  Complete submission text file 0001104659-21-049830.txt   243729

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rigl-20210413.xsd EX-101.SCH 3178
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rigl-20210413_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rigl-20210413_pre.xml EX-101.PRE 22705
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2112882d1_8k_htm.xml XML 3510
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29889 | Film No.: 21823793
SIC: 2834 Pharmaceutical Preparations